HIV and HTLV Infections and Coinfections

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".

Deadline for manuscript submissions: 1 August 2024 | Viewed by 91

Special Issue Editors


E-Mail Website
Guest Editor
Department of Internal Medicine, School of Medicine, Federal University of Bahia, Salvador, BA, Brazil
Interests: HIV; HTLV; human retroviruses
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Laboratory of Virology, Institute of Biological Sciences, Federal University of Pará (UFPA), Belém 66075-110, PA, Brazil
Interests: HTLV-1/2; HTLV-associated diseases; human retrovirology; persistent viral infections (HIV, HTLV, HCV, HBV and others)
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The concurrent presence of HIV and HTLV in an individual may give rise to interactions that impact disease progression, presenting challenges in terms of diagnosis, management and treatment. This Special Issue aims to provide insights into the causes and consequences of ongoing HIV and HTLV co-infection in the era of ART. The included studies investigate whether HTLV co-infection may enhance immune activation in individuals living with HIV during antiretroviral therapy (ART) suppression. Additionally, the focus is on exploring whether co-infected individuals face an elevated risk of opportunistic infections. The issue also addresses whether co-infected individuals may pose an increased risk of transmission to others through various routes. Clinical analyses within this Special Issue strive to strike a balance between ART for HIV and potential considerations for HTLV-1 treatment. The information gathered in this issue is expected to be of significant interest and value to the scientific, clinical and public health communities as they navigate the challenges faced by both HIV and HTLV populations.

Prof. Dr. Carlos Brites
Prof. Dr. Antonio Vallinoto
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • human T-cell leukemia virus
  • HIV
  • HTLV-associated diseases
  • HIV co-infections

Published Papers

This special issue is now open for submission.
Back to TopTop